Skip to content
healthcare.dev

Fosphenytoin Sodium

NDC 0641-6136, Fosphenytoin Sodium, injection, from Hikma Pharmaceuticals USA Inc..

Product NDC
0641-6136
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
INJECTION
Route
INTRAMUSCULAR, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077989
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6136 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FOSPHENYTOIN SODIUM50 mg/mL

Pharmacologic classes

Anti-epileptic Agent [EPC]; Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 2D6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
0641-6136-250064161362525 VIAL in 1 CARTON (0641-6136-25) / 2 mL in 1 VIAL (0641-6136-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/519a44e3-8a93-456c-b71c-894513810d45

Use it

Look up 0641-6136 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6136 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0641-6136. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.